financetom
Business
financetom
/
Business
/
Palantir Technologies Partners With Edgescale AI To Operationalize AI In Manufacturing And Utilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palantir Technologies Partners With Edgescale AI To Operationalize AI In Manufacturing And Utilities
Oct 2, 2024 11:02 PM

Palantir Technologies Inc. ( PLTR ) and Edgescale AI Inc. announced a strategic partnership to deliver Live Edge, a groundbreaking integration of Palantir Edge AI and Edgescale AI’s distributed infrastructure technology.

This collaboration aims to operationalize artificial intelligence (AI) in manufacturing, utilities, and other complex industrial environments.

According to Benzinga Pro, PLTR stock has gained over 129% in the past year. Investors can gain exposure to the stock via REX AI Equity Premium Income ETF ( AIPI ) and ProShares Big Data Refiners ETF ( DAT ) .

“Live Edge unburdens our customers from complex infrastructure requirements and overhead, accelerating delivery and time to value, and transforming how industries operate,” said Tom O’Brien, Commercial Partnerships Lead at Palantir ( PLTR ).

Also Read: Private Sector Job Gains Outpace Forecasts In September As US Adds 143,000 Jobs

By extending Palantir ( PLTR ) software on VCEs powered by Edgescale, Live Edge enables direct access to hard-to-reach operational data and automates physical processes. This multi-year partnership positions Edgescale AI and Palantir ( PLTR ) to integrate AI into critical industries for their customers.

Recently, Palantir ( PLTR ) inked a multi-year, multi-million-dollar extension of an earlier deal with APA Corporation. This deal extension builds on three years of collaboration across oil and gas company APA’s global portfolio and introduces new AI capabilities through Palantir’s Artificial Intelligence Platform (AIP) software.

Recently, Palantir’s new $99.8 million contract expanded Maven Smart System access to all military branches, enhancing interoperability and readiness.

The contract allows military services to leverage existing innovations from the Office of Secretary of Defense and NGA for integration.

Price Action: PLTR shares are trading lower by 0.88% to $36.14 premarket at last check Wednesday.

Read Next:

Palantir And APA Amp Up AI Alliance: Multi-Million Dollar Deal To Transform Oil & Gas Operations

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Northern Trust's profit surges on fee income boost, accounting gain
Northern Trust's profit surges on fee income boost, accounting gain
Jul 17, 2024
(Reuters) - Asset and wealth manager Northern Trust ( NTRS ) posted a more than two-fold jump in second-quarter profit on Wednesday, thanks to higher fee income and an accounting gain of $878.4 million from a stock exchange deal with Visa. Hopes of a soft landing for the U.S. economy and investor frenzy around artificial intelligence have lifted the stock...
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Jul 17, 2024
08:32 AM EDT, 07/17/2024 (MT Newswires) -- Prologis ( PLD ) reported Q2 core funds from operations Wednesday of $1.34 per diluted share, compared with $1.83 a year earlier. Analysts polled by Capital IQ expected $1.07. Total revenue for the quarter ended June 30 was $2.01 billion, down from about $2.45 billion a year earlier. Analysts surveyed by Capital IQ...
BioCardia Receives Patent for Morph DNA Transseptal Delivery
BioCardia Receives Patent for Morph DNA Transseptal Delivery
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology. The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said. BioCardia's (...
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday it has received regulatory clearance from the Netherlands' ethics authority to begin human testing of its IMP761 potential autoimmune disease treatment. Immutep ( IMMP ) describes IMP761 as a LAG-3 agonist antibody to potentially treat rheumatoid arthritis, type 1 diabetes, and multiple sclerosis, among other autoimmune diseases....
Copyright 2023-2026 - www.financetom.com All Rights Reserved